Filing Flows › Corcept Therapeutics (CORT) › Q2 2026
Corcept Therapeutics (CORT) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 29, 2026
Corcept Therapeutics (CORT) reported revenue of $256M for the second quarter 2026 (Q2 2026), +32% from a year earlier and +55% from the quarter before. Operating margin was 16.1%, net earnings $43.0M (16.8% of revenue).
Corcept Therapeutics, Q2 2026: revenue $256M (+32% year over year), operating margin 16.1%, net earnings $43.0M, operating cash flow $33.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $256M | +55% | +32% |
| Operating profit | $41.3M | — | +55% |
| Net earnings | $43.0M | — | +22% |
| Operating cash flow | $33.5M | — | -24% |
| Free cash flow | $31.0M | — | -30% |
What changed
Revenue was $256.1M in Q2 2026, up 32% year over year and up 55% from the previous quarter. Hypercortisolism Products was the largest line at 81% of revenue. Hypercortisolism Products added $14.2M year over year (up 7%), 23% of the total change.
Operating profit was $41.3M, a 16.1% margin (up 2.4 points year over year). Of the extra revenue versus Q2 2025, 24% reached operating profit, above the 14% margin then. Total costs grew 28% against revenue growth of 32%. The fastest-growing cost line was SG&A (+51%). Net earnings were $43.0M, up 22% year over year. The effective tax rate was 6.4%.
Operating cash flow was $33.5M (down 24% year over year), 78% of net earnings. Non-cash charges added back $863K of depreciation and amortization and $29.4M of share-based compensation. Working capital and other items used $39.7M. Capital expenditures of $2.5M left free cash flow of $31.0M.
Questions
What was Corcept Therapeutics' revenue in the second quarter 2026?
Corcept Therapeutics (CORT) reported revenue of $256M for the second quarter 2026 (Q2 2026), +32% from a year earlier and +55% from the quarter before.
Was Corcept Therapeutics profitable in the second quarter 2026?
Operating profit was $41.3M (16.1% of revenue) and net earnings $43.0M.